A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4(+) T cells

Míreanna comhchosúla

• A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4(+) T cells
  de réir: Paas-Rozner, Miri, et al.
  Foilsithe / Cruthaithe: (2003)
• Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice
  de réir: Paas-Rozner, Miri, et al.
  Foilsithe / Cruthaithe: (2000)
• A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses
  de réir: Katz-Levy, Yael, et al.
  Foilsithe / Cruthaithe: (1997)
• The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes
  de réir: Paas-Rozner, Miri, et al.
  Foilsithe / Cruthaithe: (2001)
• Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs.
  de réir: Katz-Levy, Y, et al.
  Foilsithe / Cruthaithe: (1993)